HeartSciences Inc. filed a preliminary proxy statement and issued a press release regarding its proposed all-stock business combination with Fortitude Mining Holdings, Inc., announced in June 2026. The transaction involves the issuance of approximately 107.6 million shares of new Class V Common Stock to Digital Currency Group, resulting in pro forma combined shareholders' equity of $70.0 million. HeartSciences reported no meaningful revenue for fiscal year 2026 ending April 30, 2026, with cash and equivalents of approximately $1.7 million. The filing also outlines a proposal to authorize the Board to implement a reverse stock split within a range of 1-for-2 to 1-for-5 if necessary for Nasdaq listing compliance. HeartSciences operates in the healthcare information technology sector, focusing on AI-integrated electrocardiography solutions.

HeartSciences Inc. filed its fiscal 2026 Annual Report on Form 10-K and announced it expects to file a preliminary proxy statement regarding its proposed business combination with Fortitude Mining Holdings, Inc. The company expects to issue its fiscal 2026 earnings release and a business update early next week. HeartSciences is a healthcare information technology company focused on advancing electrocardiography through artificial intelligence.

HeartSciences Inc. entered into a merger agreement on June 23, 2026, involving Fortitude Mining Holdings, Inc. and its subsidiaries to facilitate a transaction where HeartSciences becomes the sole managing member of the surviving company. In connection with the merger, the company amended the employment agreement for CFO Danielle Watson to include severance benefits and granted her 25,000 restricted stock units that vest over one year. HeartSciences is a medical technology company focused on cardiac health diagnostics.